STAT
APRIL 1, 2025
spending on prescription drugs was almost $800 billion. Although low-cost generic drugs filled 91% of all prescriptions, the 9% of prescriptions filled with a branded medicine accounted for 84% of drug spending. In 2024, total U.S.
Safe Biologics
MARCH 5, 2025
Small-molecule drugs typically come in pill or tablet form, and comprise 90% of prescriptions filled in the U.S. This disparity discourages investment in small-molecule drug research, as manufacturers have a shorter period to recoup their research and development costs. The Senate introduced its companion bill, S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ID Stewardship
JUNE 6, 2023
Patient Education and Adherence : AI chatbots or virtual assistants can be developed to provide patients with on-demand information about their medications, dosages, potential side effects, and adherence strategies. Faster and more accurate prescription filling leads to increased patient satisfaction.
Putting Patients First Blog
MAY 29, 2024
Prior authorization and association with delayed or discontinued prescription fills. Patient-focused drug development (PFDD): incorporating clinical outcome assessments into endpoints for regulatory decision-making; draft guidance for industry, Food and Drug Administration staff, and other stakeholders; availability.
Safe Biologics
MARCH 10, 2025
The consequences of the IRAs small molecule penalty, which limits the time manufacturers have to recoup investments in simpler small molecule drugs like pills, are already being felt. Small molecule drugs make up over 90% of prescriptions filled in the U.S.
Expert insights. Personalized for you.
271 
Let's personalize your content